Group 1 - The China Securities Regulatory Commission (CSRC) has issued a notice regarding the overseas issuance and listing of Yudi Robotics (Wuxi) Co., Ltd., allowing the company to issue up to 73,600,000 overseas listed ordinary shares and list them on the Hong Kong Stock Exchange [1] - A total of 33 shareholders plan to convert their combined 237,232,625 shares of unlisted domestic shares into overseas listed shares for trading on the Hong Kong Stock Exchange [1] Group 2 - The largest shareholder, Beijing Junlian Chengye Equity Investment Partnership, plans to convert 29,775,900 shares [4] - Other significant shareholders include Lazars Network Technology (Shanghai) Co., Ltd. with 29,342,250 shares and Hainan Yunfeng Fund Center (Limited Partnership) with 23,750,650 shares [4][5] - The total number of shares being converted by the listed shareholders amounts to 237,232,625 shares [5]

人民财讯12月1日电，拓普集团（601689）12月1日公告，为拓宽多元融资渠道，公司正在筹划发行境外 股份(H股)并在香港联交所上市事宜。公司正与相关中介机构就此次H股上市的具体推进工作进行商 讨，相关细节尚未确定。 ...

拓普集团公告称，为推进国际化战略、完善海外产能布局，公司正筹划发行境外股份（H股）并在香港 联交所上市。目前正与中介商讨具体推进工作，细节未确定，且不会导致控股股东和实控人变化。待确 定方案后，需经公司董事会、股东会审议及监管机构批准、核准或备案。本次H股上市存在不确定性， 公司将及时披露进展。 ...

Core Viewpoint - The company is in the process of applying for the issuance of overseas listed shares (H-shares) and plans to list on the Main Board of the Hong Kong Stock Exchange [1] Group 1 - The company has recently received a notification from the China Securities Regulatory Commission regarding the overseas issuance and listing [1] - The company intends to issue no more than 66,446,000 shares of overseas listed common stock [1] - The listing will take place on the Hong Kong Stock Exchange [1]

证券代码：688205 证券简称：德科立 公告编号：2025-065 无锡市德科立光电子技术 第二届董事会第十八次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担个别及连带责任。 一、董事会会议召开情况 无锡市德科立光电子技术股份有限公司（以下简称"公司"）第二届董事会第十八次会议于2025年11月28 日在公司会议室召开。本次会议的通知于2025年11月25日通过书面及电话等方式送达全体董事。本次会 议应参加董事9名，实际参加董事9名，会议由董事长渠建平先生主持，本次会议的召集、召开方式符合 《公司法》等法律、行政法规、部门规章、规范性文件和《公司章程》的规定。 二、董事会会议审议情况 （一）审议通过《关于公司发行S股股票并在新加坡交易所上市的议案》 为进一步提高公司综合竞争力，深入推进公司的国际化战略，同时借助国际资本市场，实现公司融资渠 道的多元化，公司拟在新加坡证券交易所有限公司（以下简称"新交所"）主板以二次上市的方式发行新 的普通股（"S股"或"股票"）并挂牌上市（以下简称"本次发行上市"）。 根据《中华人民共和 ...

智通财经APP讯，伊戈尔(002922.SZ)发布公告，为进一步推进公司国际化战略、提升公司国际形象及综 合竞争力，公司拟发行境外上市股份(H股)并申请在香港联合交易所有限公司(简称"香港联交所")主板挂 牌上市。公司将充分考虑现有股东利益及境内外资本市场情况，在股东会决议有效期内择机完成本次发 行上市。 ...

Core Points - Zhejiang Hailiang Co., Ltd. has announced a change in registered capital and amendments to its Articles of Association following the conversion of its convertible bonds into shares [1][2][36] - The registered capital will increase from 2,001,129,937 yuan to 2,291,755,274 yuan due to the conversion of 290,625,337 shares from the "Hailiang Convertible Bonds" [1][36] Group 1: Registered Capital Change - The company held its ninth board meeting on November 21, 2025, where the proposal for changing the registered capital was approved [3][4] - The conversion period for the convertible bonds was from July 1, 2025, to September 29, 2025 [1] - The amendment to the Articles of Association will be submitted for shareholder approval and will be finalized based on regulatory approval [2][36] Group 2: H-share Issuance - The board approved a proposal to issue H-shares and list them on the Hong Kong Stock Exchange to enhance international strategy and financing capabilities [5][8] - The H-shares will be ordinary shares with a par value of 1.00 yuan, and the issuance will not exceed 15% of the total share capital post-issuance [11][17] - The issuance will be conducted through public offerings in Hong Kong and international placements [15][19] Group 3: Fund Utilization - The funds raised from the H-share issuance will primarily be used for global smart production base construction, capacity expansion, R&D enhancement, brand building, strategic investments, and working capital [31]

Core Viewpoint - Longxin Co., Ltd. (688486.SH) plans to issue shares (H-shares) overseas and list on the main board of the Hong Kong Stock Exchange to enhance its international strategy and operational capabilities [1] Group 1: International Strategy - The company aims to deepen its international strategic layout to attract and gather outstanding talent [1] - The issuance of H-shares is part of the company's efforts to strengthen its overseas investment and financing capabilities [1] Group 2: Regulatory Compliance - The planned issuance and listing comply with relevant laws and regulations, including the Company Law of the People's Republic of China and the Securities Law of the People's Republic of China [1] - The company will select an appropriate timing and issuance window to complete the issuance and listing within the validity period of the shareholders' meeting resolution [1]

迈威生物晚间公告，公司于近日收到中国证监会出具的《关于迈威（上海）生物科技股份有限公司境外 发行上市备案通知书》。根据备案通知书，公司拟发行不超过6266.46万股境外上市普通股并在香港联 合交易所上市。自备案通知书出具之日起至本次境外发行上市结束前，公司如发生重大事项，应根据境 内企业境外发行上市有关规定，通过中国证监会备案管理信息系统报告。公司完成境外发行上市后15个 工作日内，应通过中国证监会备案管理信息系统报告发行上市情况。 ...

源杰科技公告称，2025年11月19日公司召开第二届董事会第二十四次会议，审议通过授权管理层启动境 外发行股份（H股）并在香港联交所上市相关筹备工作的议案，授权期限12个月。公司拟通过本次H股 上市加快国际化战略及海外业务布局。目前除已审议议案外，具体细节未确定。本次上市尚需公司董事 会、股东会审议及相关政府、监管机构备案或审核批准，存在不确定性。 ...